Knock down of timp-2 by sirna and crispr/cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

HIGHLIGHTS

• who: Ruth M. Escalona from the South, Ballarat Technology Park Central, Ballarat, VIC, Australia have published the Article: Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer, in the Journal: (JOURNAL)
• what: This study investigated the role of TIMP-2 in an cell line in which the expression of TIMP-2 was reduced by either siRNA or Methods: OVCAR5 cells were transiently and stably transfected with either single or pooled TIMP-2 siRNAs (T2-KD cells) or by under the influence of two . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.